Boehringer Canada Announces Availability of SPEVIGO® for expanded indication in Canada
The subcutaneous formulation for chronic GPP treatment was granted market authorization in July 2024 by Health Canada. SPEVIGO is a novel, selective antibody that blocks the activation of the ...
Independent Advisor Solutions Adds to Exclusive Canadian Retail Partnership with Apollo; Continues Mission to Power Advisor Portfolios
Independent Advisor Solutions Inc. (Independent Advisor Solutions)—a wholly owned subsidiary of Wellington-Altus Financial ...
Where tradition meets the future of work: 'Southwestern Ontario's Top Employers' for 2025 are announced
The economy of Southwestern Ontario, a long-settled region known for its rich history and roots in agriculture and the ...
The Challenges for Neurodiverse Students in Post-Secondary Education
OTTAWA, Ontario, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Neurodivergent students are significantly underrepresented in post-secondary education (PSE), with less than half disclosing their identity or ...